Agenus to provide corporate update and first quarter 2023 financial report

Lexington, mass.--(business wire)--agenus (nasdaq: agen), a leading immuno-oncology company specializing in immunological agents for cancer and infectious diseases, today announced the company will release its first quarter 2023 financial results before the market opens on tuesday, may 9, 2023. agenus executives will host a conference call and webcast at 8:30 a.m. et that morning to discuss the results and to provide a corporate update. conference call dial-in numbers: (646) 307-1963 (us-ny) or.
AGEN Ratings Summary
AGEN Quant Ranking